Jane Street Group, LLC Humanigen, Inc Call Options Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	SELL	$1.81 - $3.97 $45,612 - $100,044	-25,200 Reduced 8.52%	270,700 $815,000
Q4 2021 Feb 15, 2022	BUY	$3.66 - $8.22 $507,642 - $1.14 Million	138,700 Added 88.23%	295,900 $1.1 Million
Q3 2021 Nov 16, 2021	BUY	$5.93 - $17.83 $403,833 - $1.21 Million	68,100 Added 76.43%	157,200 $932,000
Q2 2021 Aug 16, 2021	SELL	$13.54 - $22.74 $434,634 - $729,954	-32,100 Reduced 26.49%	89,100 $1.55 Million
Q1 2021 May 18, 2021	BUY	$12.91 - $23.83 $1.56 Million - $2.89 Million	121,200 New	121,200 $2.32 Million

558K

Ticker HGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,661,000
Description
Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called ?cytokine storm'. Lenzilumab is an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF). The company is developing lenzilumab as a treatment for cytokine storm associated with...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.